HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA. 1986

C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
Immunology Department, Evangelismos Hospital, Athens, Greece.

Ninety-five rheumatoid arthritis patients treated with aurothiomalate and/or D-penicillamine have been studied for possible associations between HLA-A, -B, -DR antigens and various toxic reactions to the above drugs. HLA-DR3 and -DRw6 had a higher frequency in patients with toxic reactions (all types) than in patients without toxic reactions (28.5 per cent vs 13.0 per cent and 26.5 per cent vs 4.3 per cent, chi 2 = 2.6 and 7.2, respectively). HLA-B8 was found at a higher frequency in patients with proteinuria and other types of renal involvement (20.0 per cent vs 7.4 per cent in controls), whereas skin manifestations were mainly associated with the presence of HLA-DRw6. The lowest frequency of side-effects was seen in patients with HLA-DR1 and DR2 (10.2 per cent vs 28.3 per cent and 28.5 per cent vs 54.3 per cent, chi 2 = 3.9 and 5.5, respectively). In addition, seropositive patients possessing HLA-DR1, showed toxic reactions less frequently.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005260 Female Females
D006052 Gold Sodium Thiomalate A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis. Aurothiomalate,Gold Thiomalate,Sodium Gold Thiomalate,Aurolate,Gold Disodium Thiomalate, Monohydrate,Gold Thiomalic Acid,Mercaptobutanedioic Acid Monogold(1+) Sodium Salt,Miocrin,Miocrisin,Monogold (1+) Disodium Thiomalate,Myochrysine,Myocrisin,Myocrysine,Sodium Aurothiomalate,Sodium Thiomalatoaurate,Tauredon,Aurothiomalate, Sodium,Gold Thiomalate, Sodium,Sodium Thiomalate, Gold,Thiomalate, Gold,Thiomalatoaurate, Sodium
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human

Related Publications

C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
January 1986, Scandinavian journal of rheumatology,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
February 1983, Annals of the rheumatic diseases,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
November 1984, Tissue antigens,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
October 1984, The Journal of rheumatology,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
November 1997, Transplantation proceedings,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
August 1980, The New England journal of medicine,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
December 1987, The Journal of rheumatology,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
December 1983, The Journal of rheumatology,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
February 1986, Tissue antigens,
C Pachoula-Papasteriades, and K Boki, and M Varla-Leftherioti, and I Kappos-Rigatou, and G Fostiropoulos, and J Economidou
January 1984, Wiener klinische Wochenschrift. Supplementum,
Copied contents to your clipboard!